Induction therapy in multiple myeloma.

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn , Issue , 2008, Pages 306-312

  Harousseau, Jean Luc ^a  

^a HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BORONIC ACID DERIVATIVE; BORTEZOMIB; DEXAMETHASONE; PYRAZINE DERIVATIVE; THALIDOMIDE;

ARTICLE; AUTOTRANSPLANTATION; DISEASE FREE SURVIVAL; HUMAN; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; MULTIPLE MYELOMA; REMISSION; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; COMBINED MODALITY THERAPY; DEXAMETHASONE; DISEASE-FREE SURVIVAL; HUMANS; MULTIPLE MYELOMA; PYRAZINES; REMISSION INDUCTION; STEM CELL TRANSPLANTATION; SURVIVAL RATE; THALIDOMIDE; TRANSPLANTATION, AUTOLOGOUS;

EID: 67651173288     PISSN: 15204391     EISSN: None     Source Type: Journal    
DOI: 10.1182/asheducation-2008.1.306     Document Type: Article

References (0)